| Application no. and date | 11185780.1 (espacenet) (Federated) (European Patent Register), 20060828 | | Patent/reg. no. and date | DK/EP 2425715, 20140305 | | Publication date | 20120307 | | Priority no. and date | US 712390 P, 20050831 | | EP pub. no. and date |
EP 2425715 20120307 | | Effective date | | | Applicant/owner | University of Tennessee Research Foundation, 1534 White Avenue, Suite 403
Knoxville, TN 37996-1527, US | | Applicant ref. no. | P390DKEP | | Inventor | Miller, Duane D., 8706 Maple Creek Cove
Germantown, TN 38139, US,
Dalton, James T, 2706 Wellesley Drive
Upper Arlington, OH 43221, US | | Representative | JESPER LEVIN A/S, Jægersborg Alle 93, 2820 Gentofte, DK | | Opponent | | | IPC Class | A01N 37/18 (2006.01) , A61K 31/165 (2006.01) , A61P 13/12 (2006.01) , A61P 17/02 (2006.01) , A61P 19/00 (2006.01) , C07C 233/00 (2006.01) | | Title | Behandling af symptomer på nyresygdom med selektive, androgenreceptor modulatorer (SARM) | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
